Clinical Trial

Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

Recruiting
View on ClinicalTrials.gov →
Summary
A prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Tribranch Embedded Aortic Triple-branch Arch Stent Graft System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for true/pseudo aortic arch aneurysms and ulcers involving aortic arch . (GENIUS Study)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-22; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT06385379
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions Aortic Arch Aneurysm
Enrollment 90 participants
Start Date 2024-06-30
Primary Completion 2025-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01